These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 28100578)
21. Giant conjunctival squamous cell carcinoma. Treatment with surgery following topical interferon alpha-2b. Murcia Bello C; Lleó Pérez AV; Navarro Piera JF Arch Soc Esp Oftalmol; 2016 Apr; 91(4):188-90. PubMed ID: 26827157 [TBL] [Abstract][Full Text] [Related]
22. Treatment of conjunctival and corneal epithelial neoplasia with retinoic acid and topical interferon alfa-2b: long-term follow-up. Krilis M; Tsang H; Coroneo M Ophthalmology; 2012 Oct; 119(10):1969-73. PubMed ID: 22704834 [TBL] [Abstract][Full Text] [Related]
23. Risk factors for ocular surface squamous neoplasia recurrence after treatment with topical mitomycin C and interferon alpha-2b. Besley J; Pappalardo J; Lee GA; Hirst LW; Vincent SJ Am J Ophthalmol; 2014 Feb; 157(2):287-293.e2. PubMed ID: 24184223 [TBL] [Abstract][Full Text] [Related]
24. Squamous Cell Neoplasm of the Ocular Surface in a Patient With Psoriasis Treated With Tumor Necrosis Factor-Alpha Inhibitors. Lezcano Carduz VP; Mingo Botín D; Durán Poveda SP Cornea; 2015 Jul; 34(7):833-4. PubMed ID: 26010941 [TBL] [Abstract][Full Text] [Related]
25. [Complications in the treatment of ocular surface squamous neoplasia with interferon α‑2b in rheumatoid arthritis]. Torres Suárez E; Pinheiro R; Schrage N Ophthalmologe; 2017 Feb; 114(2):155-158. PubMed ID: 27300720 [TBL] [Abstract][Full Text] [Related]
26. [Conjunctival squamous cell carcinoma: paradoxical response to interferon eyedrops]. Mata E; Conesa E; Castro M; Martínez L; de Pablo C; González ML Arch Soc Esp Oftalmol; 2014 Jul; 89(7):293-6. PubMed ID: 24269461 [TBL] [Abstract][Full Text] [Related]
27. Study of efficacy and safety of reconstituted, recombinant human interferon alpha 2b eyedrops without refrigeration as a therapy for immunoreduction and/or treatment of ocular surface squamous neoplasia. Kabra NS; Patil VS; Dhanuka DG Indian J Ophthalmol; 2021 Dec; 69(12):3776-3777. PubMed ID: 34827049 [No Abstract] [Full Text] [Related]
28. Usefulness of Topical Interferon Alpha-2b Eye Drop as an Adjunctive Therapy Following Surgical Resection in Ocular Surface Squamous Neoplasia. Kanaya R; Kase S; Ishijima K; Ishida S In Vivo; 2019; 33(6):2211-2215. PubMed ID: 31662558 [TBL] [Abstract][Full Text] [Related]
29. [Topical interferon alfa-2b for primary treatment of conjunctiva-cornea intraepithelial neoplasia]. Pérez de Arcelus M; Aranguren M; Andonegui J An Sist Sanit Navar; 2012; 35(1):137-41. PubMed ID: 22552136 [TBL] [Abstract][Full Text] [Related]
32. [Interferon alpha 2b for treatment of conjunctival melanoma: a case report]. Schumacher C; Heinz C; Lommatzsch P; Lommatzsch A; Koch J Ophthalmologe; 2013 Aug; 110(8):766-9. PubMed ID: 23319061 [TBL] [Abstract][Full Text] [Related]
33. Topical interferon alpha-2b as an adjunctive therapy in recurrent conjunctival papilloma. Muralidhar R; Sudan R; Bajaj MS; Sharma V Int Ophthalmol; 2009 Feb; 29(1):61-2. PubMed ID: 18000647 [No Abstract] [Full Text] [Related]
34. Perilesional and topical interferon alfa-2b for conjunctival and corneal neoplasia. Vann RR; Karp CL Ophthalmology; 1999 Jan; 106(1):91-7. PubMed ID: 9917787 [TBL] [Abstract][Full Text] [Related]
35. Interferon alpha 2b treatment for residual ocular surface squamous neoplasia unresponsive to excision, cryotherapy and mitomycin-C. Nemet AY; Sharma V; Benger R Clin Exp Ophthalmol; 2006; 34(4):375-7. PubMed ID: 16764660 [TBL] [Abstract][Full Text] [Related]
36. Topical interferon alpha 2b eye-drops for treatment of ocular surface squamous neoplasia: a dose comparison study. Galor A; Karp CL; Chhabra S; Barnes S; Alfonso EC Br J Ophthalmol; 2010 May; 94(5):551-4. PubMed ID: 19493859 [TBL] [Abstract][Full Text] [Related]
37. Treatment of conjunctival papillomata with topical interferon Alfa-2b. Schechter BA; Rand WJ; Velazquez GE; Williams WD; Starasoler L Am J Ophthalmol; 2002 Aug; 134(2):268-70. PubMed ID: 12140037 [TBL] [Abstract][Full Text] [Related]
38. The regression time of ocular surface squamous neoplasia using topical interferon alfa-2b does not depend on the initial tumor size. Vilaltella M; Huerva V Arq Bras Oftalmol; 2021; 85(2):109-114. PubMed ID: 34431893 [TBL] [Abstract][Full Text] [Related]